Psoriasis and Breathing - slowed or stopped

Summary:

Breathing - slowed or stopped is found among people with Psoriasis, especially for people who are male, 60+ old.

The study analyzes which people have Breathing - slowed or stopped with Psoriasis. It is created by eHealthMe based on reports of 94 people who have Psoriasis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Psoriasis?

Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 1,479 drugs and 1,694 conditions by eHealthMe. Check the latest studies of Psoriasis.

What is Breathing - slowed or stopped?

Breathing - slowed or stopped is found to be associated with 1,224 drugs and 2,167 conditions by eHealthMe. Check the latest studies of Breathing - slowed or stopped.



On Jul, 10, 2026

94 people who have Psoriasis and Breathing - Slowed Or Stopped are studied.

Would you have Breathing - slowed or stopped when you have Psoriasis?

Gender of people who have Psoriasis and experienced Breathing - Slowed Or Stopped *:

  • female: 34.44 %
  • male: 65.56 %

Age of people who have Psoriasis and experienced Breathing - Slowed Or Stopped *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 1.35 %
  • 30-39: 2.7 %
  • 40-49: 16.22 %
  • 50-59: 20.27 %
  • 60+: 55.41 %

Common co-existing conditions for these people *:

  1. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 10 people, 10.64%
  2. High Blood Pressure: 7 people, 7.45%
  3. Diabetes: 6 people, 6.38%
  4. Headache (pain in head): 4 people, 4.26%
  5. Birth Control: 4 people, 4.26%
  6. Premature Labor: 4 people, 4.26%
  7. Otitis (ear infection): 4 people, 4.26%
  8. High Blood Cholesterol: 3 people, 3.19%
  9. Dyslipidaemia (abnormal amount of lipids): 3 people, 3.19%
  10. Stable Angina (a constant chest pain): 3 people, 3.19%

Common drugs taken by these people *:

  1. Humira: 30 people, 31.91%
  2. Enbrel: 13 people, 13.83%
  3. Cosentyx: 12 people, 12.77%
  4. Skyrizi: 11 people, 11.70%
  5. Coreg: 5 people, 5.32%
  6. Siliq: 5 people, 5.32%
  7. Pristiq: 5 people, 5.32%
  8. Symbicort: 5 people, 5.32%
  9. Raptiva: 5 people, 5.32%
  10. Ventolin: 5 people, 5.32%

Common symptoms for these people *:

  1. Pneumonia: 18 people, 19.15%
  2. Dyspnea (difficult or laboured breathing): 14 people, 14.89%
  3. Loss Of Consciousness: 14 people, 14.89%
  4. Malaise (a feeling of general discomfort or uneasiness): 14 people, 14.89%
  5. Cardiac Arrest: 12 people, 12.77%
  6. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 12 people, 12.77%
  7. Oxygen Saturation Decreased: 8 people, 8.51%
  8. Abdominal Pain Upper: 8 people, 8.51%
  9. Fatigue (feeling of tiredness): 8 people, 8.51%
  10. Fall: 6 people, 6.38%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Breathing - slowed or stopped?

- Check whether Breathing - slowed or stopped is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Breathing - slowed or stopped:

All the conditions that are associated with Breathing - slowed or stopped:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Breathing - slowed or stopped and Psoriasis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: